Health Care & Life Sciences » Pharmaceuticals | Pharmally International Holding Co. Ltd.

Pharmally International Holding Co. Ltd. | Balance Sheet

Fiscal year is January-December. All values TWD Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
294
979
2,631
3,830
4,245
5,219
Total Accounts Receivable
593
720
790
687
718
673
Inventories
217
258
267
214
301
320
Other Current Assets
2
3
3
20
39
55
Total Current Assets
1,107
1,959
3,691
4,751
5,303
6,266
Net Property, Plant & Equipment
1,713
1,672
2,146
2,466
3,037
3,541
Total Investments and Advances
-
-
1
80
-
-
Intangible Assets
-
-
-
-
143
142
Other Assets
100
100
96
358
334
311
Total Assets
2,925
3,739
5,943
7,665
8,829
10,272
ST Debt & Current Portion LT Debt
111
-
-
752
925
Accounts Payable
177
122
172
215
251
Income Tax Payable
71
81
32
22
46
Other Current Liabilities
148
249
192
220
295
Total Current Liabilities
507
452
396
1,209
1,517
Long-Term Debt
-
-
-
801
-
Deferred Taxes
4
1
1
3
4
Total Liabilities
515
460
404
2,017
1,524
Common Equity (Total)
2,272
3,144
5,415
5,315
6,816
Total Shareholders' Equity
2,272
3,144
5,415
5,315
6,816
Total Equity
2,272
3,144
5,415
5,541
7,206
Liabilities & Shareholders' Equity
2,925
3,739
5,943
7,665
8,829
Accumulated Minority Interest
-
-
-
226
390
Non-Equity Reserves
138
135
124
107
99

About Pharmally International Holding Co.

View Profile
Address
18th Floor
Taipei TP 11012
Taiwan
Employees -
Website http://www.pharmally.com
Updated 07/08/2019
Pharmally International Holding Co., Ltd. engages in the manufacture and sale of infusion and active pharmaceutical ingredient (API) products. It focuses on basic infusion, infusion therapy, and API. Its products include glucose, sodium chloride, glucose & sodium chloride, compound sodium chloride, lactated ringer's, dextran 40 glucose, dextran 20 glucose, ambroxol hydrochloride & glucose, levofloxacin lactate & sodium chloride injections, nikethamide, dextran powder, and levofloxacin lactate powder.